15-40471261-G-T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_130468.4(CHST14):​c.48G>T​(p.Glu16Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000203 in 1,475,360 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E16K) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000015 ( 0 hom. )

Consequence

CHST14
NM_130468.4 missense

Scores

1
2
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.85

Publications

0 publications found
Variant links:
Genes affected
CHST14 (HGNC:24464): (carbohydrate sulfotransferase 14) This gene encodes a member of the HNK-1 family of sulfotransferases. The encoded protein transfers sulfate to the C-4 hydroxyl of N-acetylgalactosamine residues in dermatan sulfate. Mutations in this gene have been associated with adducted thumb-clubfoot syndrome.[provided by RefSeq, Mar 2010]
CHST14 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome, musculocontractural type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Ehlers-Danlos syndrome, musculocontractural type
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0060471296).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHST14NM_130468.4 linkc.48G>T p.Glu16Asp missense_variant Exon 1 of 1 ENST00000306243.7 NP_569735.1 Q8NCH0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHST14ENST00000306243.7 linkc.48G>T p.Glu16Asp missense_variant Exon 1 of 1 6 NM_130468.4 ENSP00000307297.6 Q8NCH0
CHST14ENST00000559991.1 linkc.48G>T p.Glu16Asp missense_variant Exon 1 of 2 5 ENSP00000453882.1 H0YN65
ENSG00000302612ENST00000788112.1 linkn.151+394C>A intron_variant Intron 1 of 4

Frequencies

GnomAD3 genomes
AF:
0.00000658
AC:
1
AN:
151976
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000255
AC:
2
AN:
78506
AF XY:
0.0000221
show subpopulations
Gnomad AFR exome
AF:
0.000919
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000229
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000151
AC:
2
AN:
1323384
Hom.:
0
Cov.:
32
AF XY:
0.00000307
AC XY:
2
AN XY:
652410
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
25982
American (AMR)
AF:
0.0000406
AC:
1
AN:
24644
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22356
East Asian (EAS)
AF:
0.0000325
AC:
1
AN:
30762
South Asian (SAS)
AF:
0.00
AC:
0
AN:
72044
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33530
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3980
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1055242
Other (OTH)
AF:
0.00
AC:
0
AN:
54844
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000658
AC:
1
AN:
151976
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74228
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41418
American (AMR)
AF:
0.00
AC:
0
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10562
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67954
Other (OTH)
AF:
0.00
AC:
0
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.625
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756
ExAC
AF:
0.0000242
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Cardiovascular phenotype Uncertain:1
Mar 15, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.48G>T (p.E16D) alteration is located in exon 1 (coding exon 1) of the CHST14 gene. This alteration results from a G to T substitution at nucleotide position 48, causing the glutamic acid (E) at amino acid position 16 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.015
T;.
Eigen
Benign
-0.37
Eigen_PC
Benign
-0.22
FATHMM_MKL
Benign
0.74
D
LIST_S2
Benign
0.44
T;T
M_CAP
Uncertain
0.20
D
MetaRNN
Benign
0.0060
T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.34
N;.
PhyloP100
1.9
PrimateAI
Pathogenic
0.90
D
PROVEAN
Benign
-0.20
N;N
REVEL
Benign
0.17
Sift
Benign
0.046
D;D
Sift4G
Benign
0.25
T;T
Polyphen
0.012
B;.
Vest4
0.062
MutPred
0.092
Gain of MoRF binding (P = 0.1327);Gain of MoRF binding (P = 0.1327);
MVP
0.24
MPC
0.83
ClinPred
0.015
T
GERP RS
2.9
PromoterAI
0.052
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.13
gMVP
0.40
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs759613375; hg19: chr15-40763460; API